cervical cancer treatment options - Yahoo Search Results

Ads
related to: cervical cancer treatment options
Advanced Cervical Cancer - Previously Treated

www.metastaticcervicalcancer.com
Learn More About A Different FDA-Approved Treatment For Your Patients. Read The Data On Treatment For Previously-Treated Recurrent Or Metastatic Cervical Cancer.
Watch The Video · Learn About Safety · Get Patients Access · See The Data
Types: Professional Info, Download Resources, See Clinical Study, Give Them An Option
Support Resources
HCPs Learn More Here

Get Access To Helpful Resources

Comprehensive Care
Getting Patients Started

Dosing Administration Info

Efficacy Data
See Overall Survival Data

Phase 3 Clinical Trial Info

Mechanism Of Action
Explore The MOA Here

Mechanism of Action Information
Advanced Cervical Cancer - Official Patient Website

www.cervicalcancerinfo.com
Let's Fight Previously-Treated Advanced Cervical Cancer Together. Learn More Here. Patients, Fighting Previously-Treated Advanced Cervical Cancer Can Take A Lot Of Support.
A Different Option · Learn About Treatment · Explore Information · You May Not Know
Types: Patients & Caregivers, Access Treatment, Download Resources, Ask Your Doctor
Advanced Cervical Cancer
Clinical Study Trials
Hear From a Patient
Access & Reimbursement

Search results

- Scientists predict cancer risk on the basis of national health data
  Medical Xpress· 4 days ago
  This statistical study is a proof of concept, but the analysis suggests the model could be adapted...
- U.K. Startup Launches HPV Testing Tampons To Fight Cervical Cancer
  Forbes· 6 days ago
  Pap smears are an uncomfortable, awkward and even painful process for many women. One London-based...
- Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024
  KTLA-TV Los Angeles· 3 days ago
  Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies for cancers, announced ...
- Regeneron (REGN) Announces Positive Data on Oncology Candidate
  Zacks via Yahoo Finance· 3 days ago
  Regeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor...
- Cancer in Canada: Increasing Cases, Decreasing Diagnoses
  Medscape· 6 days ago
  The numbers of cancer cases and deaths are rising in Canada, even as overall rates of cancer...
- MD Anderson Research Highlights: ASCO 2024 Special | Newswise
  Newswise· 4 days ago
  The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
- Dr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
  Zacks via Yahoo Finance· 5 days ago
  Dr. Reddy's (RDY) announces entering into a license and supply agreement with Alvotech to develop...
- Cancer Clinical Trial Participation May Not Actually Improve Survival, Study Says
  MedPage Today· 5 days ago
  Cancer clinical trial participation was not associated with longer survival after accounting for...
- Genetic cancer screening: Learning more about lesser known hereditary cancers
  WTAE Pittsburgh· 7 days ago
  According to the National Cancer Institute, these inherited variants are thought to contribute to...
- Small Business - Shelby County Reporter | Shelby County Reporter
  The Shelby County Reporter· 4 days ago
  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive new results from an ongoing Phase 1/2 trial evaluating its first-in-class costimulatory bispecific antibody, REGN7075 ...